• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏结节病:诊断与管理

Cardiac sarcoidosis: diagnosis and management.

作者信息

Bussinguer Michelle, Danielian Alfred, Sharma Om P

机构信息

Division of Pulmonary and Critical medicine, Keck School of Medicine of USC, Los Angeles, CA, USA,

出版信息

Curr Treat Options Cardiovasc Med. 2012 Dec;14(6):652-64. doi: 10.1007/s11936-012-0208-3.

DOI:10.1007/s11936-012-0208-3
PMID:22983661
Abstract

Cardiac sarcoidosis can be life threatening if not promptly diagnosed and treated appropriately and aggressively. The diagnosis of myocardial disease is often difficult and circumstantial because there are no reliable diagnostic tests. Except for the finding of noncaseating granulomas on endomyocardial biopsy, most tests are limited and nonspecific. Therefore, the decision of initiating treatment is based on the patient's symptoms and the course of the disease, rather than on the presence of histologic confirmation. The goal of therapy is to prevent irreversible cardiomyopathy and to thwart the progression to heart transplantation. The mainstay of treatment is corticosteroids, although there are no large randomized trials analyzing corticosteroid use. The combination with other immunosuppressant agents, such as Methotrexate and Azathioprine, is initiated on the patient's failing or experiencing severe side effects from corticosteroids. While there are small studies proving the efficacy of tumor necrosis factor-inhibitors in cardiac sarcoidosis, more experience with these agents is needed. Catheter ablation or placement of implantable devices is indicated prophylactically in patients with severe ventricular tachyarrhythmias. Heart transplantation should be considered in patients with severe heart failure refractory to medical therapy. This article focuses on the current diagnostic tests and treatment recommendations for cardiac sarcoidosis.

摘要

心脏结节病若不及时诊断并给予恰当积极的治疗,可能会危及生命。心肌病的诊断往往困难且需依据具体情况,因为尚无可靠的诊断测试。除了心内膜活检发现非干酪样肉芽肿外,大多数检查都有局限性且缺乏特异性。因此,启动治疗的决策基于患者的症状和疾病进程,而非组织学确诊情况。治疗的目标是预防不可逆的心肌病,并阻止病情发展至心脏移植。治疗的主要手段是使用皮质类固醇,尽管尚无大型随机试验分析皮质类固醇的使用情况。当患者对皮质类固醇治疗无效或出现严重副作用时,可加用其他免疫抑制剂,如甲氨蝶呤和硫唑嘌呤。虽然有小型研究证明肿瘤坏死因子抑制剂对心脏结节病有效,但还需要更多关于这些药物的经验。对于有严重室性快速心律失常的患者,预防性地进行导管消融或植入可植入设备。对于药物治疗难治的严重心力衰竭患者,应考虑心脏移植。本文重点介绍了心脏结节病目前的诊断测试和治疗建议。

相似文献

1
Cardiac sarcoidosis: diagnosis and management.心脏结节病:诊断与管理
Curr Treat Options Cardiovasc Med. 2012 Dec;14(6):652-64. doi: 10.1007/s11936-012-0208-3.
2
Cardiac sarcoidosis: a comprehensive review.心脏结节病:全面综述。
Arch Med Sci. 2011 Aug;7(4):546-54. doi: 10.5114/aoms.2011.24118. Epub 2011 Sep 2.
3
Current Practices and Emerging Therapies to Optimize Heart Failure Management in Cardiac Sarcoidosis: A Systematic Review.优化心脏结节病心力衰竭管理的当前实践与新兴疗法:一项系统评价
Cureus. 2024 Aug 9;16(8):e66515. doi: 10.7759/cureus.66515. eCollection 2024 Aug.
4
Cardiac sarcoidosis: the challenge of radiologic-pathologic correlation: from the radiologic pathology archives.心脏结节病:放射学与病理学相关性的挑战:来自放射病理学档案
Radiographics. 2015 May-Jun;35(3):657-79. doi: 10.1148/rg.2015140247.
5
Cardiac manifestations of sarcoidosis and therapeutic options.结节病的心脏表现及治疗选择。
Cardiol Rev. 2009 Jul-Aug;17(4):153-8. doi: 10.1097/CRD.0b013e3181a1f763.
6
Pathophysiology and clinical management of cardiac sarcoidosis.心脏结节病的病理生理学和临床管理。
Nat Rev Cardiol. 2015 May;12(5):278-88. doi: 10.1038/nrcardio.2015.22. Epub 2015 Feb 24.
7
Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies.心脏结节病的组织学诊断率:心内膜心肌活检评估
Am Heart J. 1999 Aug;138(2 Pt 1):299-302. doi: 10.1016/s0002-8703(99)70115-8.
8
Diagnoses, management patterns, and outcomes of cardiac sarcoidosis in South Africa.南非心脏结节病的诊断、管理模式及治疗结果
Heart Rhythm O2. 2023 Apr 23;4(6):343-349. doi: 10.1016/j.hroo.2023.04.004. eCollection 2023 Jun.
9
[Central nervous system involvement of sarcoidosis: diagnosis and management].[结节病的中枢神经系统受累:诊断与管理]
Rinsho Shinkeigaku. 2012;52(11):1237-9. doi: 10.5692/clinicalneurol.52.1237.
10
Usefulness of electron microscopy in the diagnosis of cardiac sarcoidosis.电子显微镜检查在心脏结节病诊断中的应用价值。
Heart Vessels. 1995;10(5):275-8. doi: 10.1007/BF01744907.

引用本文的文献

1
Real-Life Utilization of Criteria Guidelines for Diagnosis of Cardiac Sarcoidosis (CS).心脏结节病(CS)诊断标准指南在实际生活中的应用
J Clin Med. 2023 Aug 14;12(16):5278. doi: 10.3390/jcm12165278.
2
Prognosis and Outcomes of Clinically Diagnosed Cardiac Sarcoidosis Without Positive Endomyocardial Biopsy Findings.临床诊断为心脏结节病但心内膜心肌活检结果为阴性的患者的预后和结局
JACC Asia. 2021 Dec 7;1(3):385-395. doi: 10.1016/j.jacasi.2021.09.005. eCollection 2021 Dec.
3
Perspective of sarcoidosis in terms of rheumatology: a single-center rheumatology clinic experience.

本文引用的文献

1
Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias.当代导管消融治疗心律失常的主要并发症的发生率及预测因素。
Heart Rhythm. 2011 Nov;8(11):1661-6. doi: 10.1016/j.hrthm.2011.05.017. Epub 2011 May 27.
2
Detection of myocardial damage in patients with sarcoidosis.结节病患者心肌损伤的检测
Circulation. 2009 Nov 17;120(20):1969-77. doi: 10.1161/CIRCULATIONAHA.109.851352. Epub 2009 Nov 2.
3
Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009.
结节病在风湿病学方面的视角:单中心风湿病诊所经验
Rheumatol Int. 2022 Dec;42(12):2191-2197. doi: 10.1007/s00296-022-05193-2. Epub 2022 Aug 25.
4
Ten Questions Cardiologists Should Be Able to Answer About Cardiac Sarcoidosis: Case-Based Approach and Contemporary Review.心脏病专家应能回答的关于心脏结节病的十个问题:基于病例的方法与当代综述
CJC Open. 2020 Dec 26;3(4):532-548. doi: 10.1016/j.cjco.2020.11.022. eCollection 2021 Apr.
5
Extrapulmonary manifestations of sarcoidosis.结节病的肺外表现。
Rheum Dis Clin North Am. 2013 May;39(2):277-97. doi: 10.1016/j.rdc.2013.02.007. Epub 2013 Mar 13.
国际心肺移植学会登记处:2009年第26份成人心脏移植官方报告
J Heart Lung Transplant. 2009 Oct;28(10):1007-22. doi: 10.1016/j.healun.2009.08.014.
4
Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies.心房颤动的当代管理:抗凝及侵入性管理策略的最新进展
Mayo Clin Proc. 2009 Jul;84(7):643-62. doi: 10.1016/S0025-6196(11)60754-4.
5
Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry.射频导管消融术在心脏结节病室性心动过速治疗中的作用:多中心注册研究报告
Heart Rhythm. 2009 Feb;6(2):189-95. doi: 10.1016/j.hrthm.2008.10.039. Epub 2008 Oct 30.
6
Cardiac sarcoidosis.心脏结节病
Am Heart J. 2009 Jan;157(1):9-21. doi: 10.1016/j.ahj.2008.09.009. Epub 2008 Nov 12.
7
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.《美国心脏病学会/美国心脏协会/心律学会2008年心脏节律异常器械治疗指南》:美国心脏病学会/美国心脏协会实践指南工作组(修订ACC/AHA/NASPE 2002年心脏起搏器和抗心律失常器械植入指南更新的写作委员会)报告,与美国胸外科协会和胸外科医师学会合作制定。
J Am Coll Cardiol. 2008 May 27;51(21):e1-62. doi: 10.1016/j.jacc.2008.02.032.
8
A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis.英夫利昔单抗治疗活动性肺结节病患者的双盲、随机、安慰剂对照试验。
Sarcoidosis Vasc Diffuse Lung Dis. 2006 Oct;23(3):201-8.
9
The pathology of pulmonary sarcoidosis: update.肺结节病的病理学:最新进展
Semin Diagn Pathol. 2007 Aug;24(3):150-61. doi: 10.1053/j.semdp.2007.06.002.
10
Outcome of heart transplantation in patients with sarcoid cardiomyopathy.结节病性心肌病患者心脏移植的结局
J Heart Lung Transplant. 2007 Jul;26(7):714-7. doi: 10.1016/j.healun.2007.05.006.